Vector Science Partners With Whoopi Goldberg for Peptide Wellness Line

The deal involves a Simple Agreement for Future Equity (SAFE) investment, signaling a long-term commitment to integrating Vector’s manufacturing expertise into the Whoopi Wellness portfolio. While peptides are typically unstable in liquid form, Vector plans to utilize its intellectual property—including 15 pending patent applications—to create shelf-stable liquid and gel formulations. This technology allows for advanced transdermal delivery, ensuring that the molecules retain their potency for consumer use.

Whoopi Goldberg, co-founder of the wellness brand, noted that the partnership centers on bringing scientific rigor to personal care products. Bill Jackson, CEO of Vector, emphasized that the exclusive arrangement provides his company with early exposure to the wellness market while demonstrating the safety standards of their cGMP-compliant manufacturing processes. For Whoopi Wellness, the move represents an effort to bolster consumer trust through high-quality, rigorously tested ingredients as the company expands its reach in the beauty and intimate care sectors.